Q1 2012

Filed May 14, 2012 · 10-Q · 44 days after period end · 0001193125-12-231684

Q1 2012 · 10-Q

Revenue—

Net Income

-$1.93M

no prior Q1 2011 on file

EPS Diluted

-$0.04

no prior Q1 2011 on file

Operating Income-$1,905,000—

Operating Cash Flow-$1,209,000—

Same quarter

no prior Q1 2011 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2012 · filed May 14, 2012 · 44 d after period end

Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR